"One of my favorite parts about working at Genentech has been seeing results from my own team’s analyzes being used to drive clinical decisions. The fulfillment of knowing you’re helping patients is so much greater than any paper acceptance."
While my experience with microbes began in the skin, at Genentech, I shifted my focus inward to our gut microbiome. As a scientist in Cancer Immunology, my group leverages clinical samples to understand how gut microbes impact systemic anti-tumor immunity and response to checkpoint inhibitors. By unlocking this new set of variables, we hope to discover new microbial biomarkers and unconventional targets for drug development.
J Exp Med (2021) 218 (1): e20200606.
Nature 514 (7520), 59-64
Cell 165 (4), 854-866
Science translational medicine 9 (397)
Science 351 (6270), 224-226